KOBAYASHI PHARMACEUTICALS financial statements, including revenue, expenses, profit, and loss
The total revenue of 4967 for the last quarter is 54.34 B JPY, and it's 19.45% higher compared to the previous quarter. The net income of Q4 23 is 4.84 B JPY.